Aemetis, Inc. Reports Second‑Quarter 2026 Financial Results While Expanding its Indian Biodiesel Operations
Aemetis, Inc. (NASDAQ: AMTX) released its second‑quarter 2026 financial results on August 6, 2026, and simultaneously announced the launch of a major biodiesel supply program in India. The company’s quarterly performance and strategic expansion underscore its dual focus on biotechnology‑driven biofuels and renewable natural gas.
Second‑Quarter Financial Highlights
Aemetis reported its first set of earnings for the fiscal year 2026, following its earlier announcement on August 4 that the company’s subsidiary, Universal Biofuels, had secured a sizable biodiesel contract with three Indian Oil Marketing Companies (OMCs). While specific revenue and earnings figures for Q2 were not disclosed in the press release, the company’s overall market position is evident: it operates a diversified portfolio of renewable natural gas (RNG) and biofuel assets across the United States and India.
The company’s key financial metrics at the close of the market day on August 4, 2026, include:
- Stock price: $1.55 per share
- 52‑week high: $3.80 (dated May 4, 2026)
- 52‑week low: $1.30 (dated December 29, 2025)
- Market capitalization: $110.5 million
- Price‑to‑earnings ratio: –1.29 (negative, reflecting current losses)
These figures highlight that while Aemetis remains a growth‑stage enterprise, its stock is trading at a discount relative to its historical peak. The company’s negative P/E ratio indicates that investors are pricing in continued investments rather than immediate profitability.
Expansion of Universal Biofuels in India
On August 4, 2026, Aemetis announced that its Indian subsidiary, Universal Biofuels, had begun deliveries under a $17 million allocation from the Indian OMCs. The allocation covers more than 18 million liters of biodiesel to be supplied over a three‑month period, with an estimated revenue of $17 million. This deal is part of India’s National Policy on Biofuels, which aims to increase biodiesel blending from the current 1 % to 5 % by 2030.
Universal Biofuels is described as one of the largest biodiesel producers in India, operating a 80‑million‑gallon‑per‑year plant in Kakinada. The company has expanded its proprietary enzymatic process to lower carbon intensity and reduce production costs. Beyond biodiesel, Universal Biofuels is exploring diversification into dairy biogas, ethanol, and sustainable aviation fuel, and is evaluating a potential initial public offering of a minority stake on the Indian stock exchange.
Broader Corporate Footprint
Aemetis’ operations extend beyond India. In the United States, the company owns and operates:
- A 65‑million‑gallon‑per‑year ethanol facility near Modesto, California, supplying animal feed to about 80 dairies.
- A network of biogas digesters and a pipeline system in California that converts dairy waste gas into renewable natural gas.
Additionally, Aemetis is developing a sustainable aviation fuel plant and a CO₂ sequestration project in California. These ventures reinforce the company’s commitment to lowering energy costs and reducing emissions through innovative biotechnology.
Market Reception
The news of the Indian biodiesel contract sent Aemetis shares higher, as reflected in the August 4, 2026 market data. The company’s stock rose on both the U.S. and German financial news outlets following the announcement, indicating investor confidence in the expanding biodiesel business. The contract also aligns with broader global trends favoring renewable fuels, particularly in markets seeking to reduce dependence on imported crude oil.
Outlook
While the company’s Q2 2026 results did not provide detailed earnings data, the combination of a substantial biodiesel contract in India, ongoing expansion of its U.S. renewable natural gas pipeline, and future projects in aviation fuel and CO₂ capture suggests a robust growth trajectory. Investors will likely monitor the company’s ability to convert its expansive technology portfolio into consistent profitability and the impact of the Indian market on its revenue mix.
The company’s official communications remain open for further updates, with investor relations contacts listed for inquiries and detailed financial disclosures.
